Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1) (Middle Region) Peptide

GPD1 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN977582

Quick Overview for Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1) (Middle Region) Peptide (ABIN977582)

Target

GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-GPD1 antibody (Catalog #: ARP42228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    GPD1 (Glycerol-3-Phosphate Dehydrogenase 1 (Soluble) (GPD1))

    Background

    GPD1L belongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Defects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) and sudden infant death syndrome (SIDS).

    Alias Symbols: FLJ26652, HTGTI

    Protein Interaction Partner: MDH1,PTN,PTN

    Protein Size: 349

    Molecular Weight

    37 kDa

    Gene ID

    2819

    NCBI Accession

    NM_005276, NP_005267

    UniProt

    P21695
You are here:
Chat with us!